-
STATEMENT: ELI LILLY’S PHASE 2 DONANEMAB STUDY RESULT IS CAUSE FOR CELEBRATION Posted on by Taylor Disselhorst in Press Releases
-
STATEMENT: BIOGEN AND APPLE PARTNERSHIP SPEEDS SEARCH FOR ALZHEIMER’S TEST; SHOULD PRIORITIZE DIVERSITY Posted on by Taylor Disselhorst in Press Releases
-
Aducanumab for Alzheimer’s: One Drug, Two Results Posted on by Taylor Disselhorst in In the News
-
Chris Sprowls Reaches Across the Aisle to Name Matt Willhite to Alzheimer’s Disease Advisory Committee Posted on by Taylor Disselhorst in In the News
-
Alzheimer’s Disease: An Epidemic in Rural America Posted on by Taylor Disselhorst in In the News
-
Investment in Diversity and Rapid, Early Diagnostics Is Essential to the Search for a Cure for Alzheimer’s Disease Posted on by Taylor Disselhorst in Press Releases
-
Running Clinical Trials in a Pandemic Posted on by Taylor Disselhorst in In the News
-
Clinical Trial for Alzheimer’s Drug, Aducanumab Shows Promise Posted on by Taylor Disselhorst in In the News
-
There is Reason for Hope as Alzheimer’s Awareness Month Comes to a Close Posted on by Taylor Disselhorst in In the News
-
Potential for an Alzheimer’s Treatment Appears to be Closer Than Ever Posted on by Taylor Disselhorst in Featured&In the News
